SCHEMBL2867324

SCHEMBL2867324

O=C(O)c1ccc2[nH]nc(-c3cnc4ccccc4c3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.56
PIM3 Q86V86 1/20 0.56
PIM2 Q9P1W9 1/20 0.56
MGAM O43451 1/20 0.52
MAP2K4 P45985 6/20 0.51
MAPK1 P28482 8/20 0.51
MAPK6 Q16659 4/20 0.51
MAPKAPK3 Q16644 3/20 0.51
ITK Q08881 1/20 0.48
MAPK3 P27361 2/20 0.45
LRRK2 Q5S007 1/20 0.44
MAP4K4 O95819 1/20 0.44
CSNK1G2 P78368 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
MAP4K5 Q9Y4K4 1/20 0.44
TOP2A P11388 1/20 0.44
TOP2B Q02880 1/20 0.44
DYRK1A Q13627 2/20 0.44
BMPR1B O00238 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373231 0.89 PIM1 (0.58) PIM1PIM3PIM2MAP2K4MAPK1
SCHEMBL2860104 0.86 PIM1 (0.53) PIM1PIM3PIM2MAP2K4MAPK1
SCHEMBL2855850 0.82 MAP2K4 (0.59) MAP2K4MAPK1MAPK6MAPKAPK3ITK
SCHEMBL2866791 0.81 MAP2K4 (0.69) MAP2K4MAPK1MAPK6MAPKAPK3ITK
SCHEMBL17179205 0.80 PIM1 (0.60) PIM1PIM3PIM2ITKLRRK2
SCHEMBL2867170 0.79 ITK (0.52) MGAMMAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL2864493 0.78 DYRK1A (0.46) DYRK1A
SCHEMBL13198203 0.78 DYRK1A (0.46) DYRK1A
SCHEMBL5377743 0.77 PIM1 (0.61) PIM1PIM3PIM2LRRK2DYRK1A
SCHEMBL2864569 0.77 MAP2K4 (0.52) MAP2K4MAPK1MAPK6MAPKAPK3ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PIM1 247/4885PIM3 236/4885PIM2 409/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 PIM1 194/4885PIM3 209/4885PIM2 388/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PIM1 247/4885PIM3 236/4885PIM2 409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.